Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
Samia E. Omer, Tawasol M. Ibrahim, Omer A. Krar, et al.
Biochemistry and Biophysics Reports (2022) Vol. 29, pp. 101225-101225
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors
Rabia Basri, Saeed Ullah, Ajmal Khan, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106739-106739
Closed Access | Times Cited: 22
Drug Repurposing using Artificial Intelligence, Molecular Docking, and Hybrid Approaches: A Comprehensive Review in General Diseases vs Alzheimer's Disease
Natasha Azeelen Zulhafiz, Teoh Teik Toe, Ai‐Vyrn Chin, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 261, pp. 108604-108604
Closed Access
Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies
Nihal Abdelmoniem, Marwa H. Abdallah, Rua M. Mukhtar, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1771-1771
Open Access | Times Cited: 18
A novel immunosensor based on cobalt oxide nanocomposite modified single walled carbon nanohorns for the selective detection of aflatoxin B1
Chulalak Damphathik, Chomphunuch Songsiriritthigul, Jamras Lerdsri, et al.
Talanta (2023) Vol. 258, pp. 124472-124472
Closed Access | Times Cited: 15
Targeting the omicron variant of SARS-CoV-2 with phytochemicals from Saudi medicinal plants: molecular docking combined with molecular dynamics investigations
Lina Eltaib, Abdulrahim A. Alzain
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9732-9744
Closed Access | Times Cited: 15
Turning down PI3K/AKT/mTOR signalling pathway by natural products: an in silico multi-target approach
N. Abd Emoniem, Rua M. Mukhtar, Hiba Ghaboosh, et al.
SAR and QSAR in environmental research (2023) Vol. 34, Iss. 2, pp. 163-182
Closed Access | Times Cited: 7
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1553-1567
Open Access | Times Cited: 12
Unlocking the potential of approved drugs for the allosteric inhibition of tropomyosin-receptor kinase A using molecular docking and molecular dynamics studies
Rua M. Mukhtar, Nihal Abdelmoniem, Hisham A. Elrufaie, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 6
Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
Shailima Rampogu, Tae Sung Jung, Min Woo Ha, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Network pharmacology integrated molecular docking of fucoidan against oral cancer and in vitro evaluation- A study using GEO datasets
Arul Jayanthi Antonisamy, Karthikeyan Rajendran, Premnath Dhanaraj
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-24
Closed Access | Times Cited: 1
Design, synthesis and computational study of benzimidazole derivatives as potential anti-SARS-CoV-2 agents
Mokaddas Flora Ananta, Poushali Saha, Fahad Imtiaz Rahman, et al.
Journal of Molecular Structure (2024) Vol. 1306, pp. 137940-137940
Closed Access | Times Cited: 1
Dual targeting inhibitors for HIV-1 capsid and cyclophilin A: molecular docking, molecular dynamics, and quantum mechanics
Fauad O. Obubeid, Maha M. Eltigani, Rua M. Mukhtar, et al.
Molecular Simulation (2022) Vol. 48, Iss. 16, pp. 1476-1489
Closed Access | Times Cited: 8
Insights from computational studies on the potential of natural compounds as inhibitors against SARS-CoV-2 spike omicron variant
Abdulrahim A. Alzain
SAR and QSAR in environmental research (2022) Vol. 33, Iss. 12, pp. 953-968
Closed Access | Times Cited: 7
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
Denis N. Prada Gori, Santiago Matías Ruatta, Martín Fló, et al.
Frontiers in Drug Discovery (2023) Vol. 2
Open Access | Times Cited: 3
Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles
Abdalrahim M. Ali, Alaa A. Makki, Walaa Ibraheem, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2289-2289
Open Access | Times Cited: 3
Insights into the Inhibition of Mycolic Acid Synthesis by Cytosporone E Derivatives for Tuberculosis Treatment Via an In Silico Multi-target Approach
Abdulrahim A. Alzain, Alaa A. Makki, Walaa Ibraheem
Chemistry Africa (2023) Vol. 6, Iss. 4, pp. 1811-1831
Closed Access | Times Cited: 2
Deciphering the molecular details of interactions between anti-COVID drugs and functional human proteins: in silico approach
Valeriya Trusova, Olga Zhytniakivska, Uliana Tarabara, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 233, pp. 115448-115448
Closed Access | Times Cited: 2
SARS‐CoV‐2 main protease mutation analysis via a kinematic method
Xiyu Chen, Sigrid Leyendecker, Henry van den Bedem
Proteins Structure Function and Bioinformatics (2023) Vol. 91, Iss. 11, pp. 1496-1509
Open Access | Times Cited: 2
Halo-bridged Cu(II) complexes with pyridine–pyrazole ligands: Influence of halogen and ligand lipophilicity on antimicrobial activity
Venugopalsamy J. Tamilpriyai, Palaniyappan Nagarasu, Karnan Singaravelu Dharshini, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136414-136414
Closed Access | Times Cited: 2
The effect of Glycyrrhiza glabra extracts on inhibiton of 3Clpro
Erhan Canbay, Meltem Kocamanoğlu, Cemrehan Fedacı, et al.
Ege Tıp Dergisi (2024) Vol. 63, Iss. 2, pp. 271-281
Open Access
BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening
Rojalin Nayak, Bibekanand Mallick
Cancer Genetics (2024) Vol. 288-289, pp. 20-31
Closed Access
Drug Repurposing Through Molecular Docking
Rati Kailash Prasad Tripathi
Advances in medical technologies and clinical practice book series (2024), pp. 247-286
Closed Access
Computational biology approaches for drug repurposing
Tanya Waseem, Tausif Ahmed Rajput, Muhammad Saqlain Mushtaq, et al.
Progress in molecular biology and translational science (2024), pp. 91-109
Closed Access
Deep Learning in Drug Repurposing: A Review of the CoV-DrugX Module within the CoV-DrugX Pipeline
Agrima Chopra, Apurva Rustagi, Sumit Tanwar, et al.
(2024)
Open Access
In Silico Molecular Docking Analysis for Repurposing Chalcone Derivatives Against Breast Cancer
Saptarshi Samajdar
(2024)
Closed Access
Page 1 - Next Page

Scroll to top